盐酸小檗碱水合物 | 68030-18-2

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 原小檗碱生物碱及其衍生物
• 中文名称: 盐酸小檗碱水合物
• 英文名称: berberine chloride hydrate
• 英文别名: berberine hydrochloride hydrate；16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride;hydrate
• CAS: 68030-18-2
• 化学式: C₂₀H₁₈NO₄*Cl*H₂O
• 分子量: 389.835
• InChiKey: BPNJXFPOPCFZOC-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -0.72
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  41.8
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  盐酸小檗碱水合物 190.0 ℃ 、4.0 kPa 条件下， 反应 2.0h， 以80%的产率得到小檗红碱
  参考文献：
  名称：

  一种9-O取代苯氧烷基小檗碱衍生物的合成方法

  摘要：

  本发明公开了一种9‑O取代苯氧烷基小檗碱衍生物的合成方法。该方法是以溴化四丁基铵作为相转移催化剂，DMF为溶剂，先通过α,ω‑二溴烷烃与苯酚反应合成溴代烷基苯基醚，再与小檗红碱直接反应，反应的温度为80℃，反应的时间为4h。反应结束后趁热倒入冰水中、冷却析出固体，再通过过滤、二氯甲烷和无水甲醇(V/V＝10:1)重结晶，得到黄色粉末状固体为9‑O取代苯氧烷基小檗碱。本发明与传统的合成9‑O取代苯氧烷基小檗碱的方法相比较，具有反应条件温和、效率高、副产物少、时间短、操作简单、产品色泽好、纯度高等优点，具有较高的实际应用前景。

  公开号：

  CN108948000A

文献信息

• [EN] NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS<br/>[FR] NOUVEAUX AGENTS DE CIBLAGE POUR INDICATIONS DIAGNOSTIQUES ET THÉRAPEUTIQUES
  申请人：APOSENSE LTD

  公开号：WO2013150534A1

  公开（公告）日：2013-10-10

  The invention relates to compounds and use thereof in the diagnosis and/or in treatment of medical disorders. In some embodiments, the compounds may be used for detecting a cancer. The compound may include a di-acid moiety. In some embodiments the di-acid moiety comprises a di-carboxylic acid and in some embodiments the di- acid moiety comprises a di-tetrazole.

  该发明涉及化合物及其在诊断和/或治疗医疗疾病中的用途。在某些实施例中，这些化合物可用于检测癌症。该化合物可能包括二酸基团。在某些实施例中，二酸基团包括二羧酸，而在某些实施例中，二酸基团包括二四唑。
• COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME
  申请人：KH NEOCHEM CO., LTD.

  公开号：US20130123494A1

  公开（公告）日：2013-05-16

  The present invention provides a complex compound, etc., which has superior moisture- and heat-resistances, etc. and is used for an optical recording medium, including: a compound represented by Formula (I) below [in the formula, R 1 represents an alkyl group which may have one or more substituents, etc., R 2 represents a cyano group, etc., R 3 represents an alkyl group which may have one or more substituents, etc., R 4 represents a hydrogen atom, etc., R 5 represents Formula (III) (in the formula, the ring A represents a heterocycle which may have one or more substituents, wherein the heterocycle is any one selected from a pyrimidine ring, a tetrazole ring, etc.)]; a metal; and any one ion selected from the group consisting of an ion formed by addition of one or more protons to an amine, an ammonium ion and a quaternary ammonium ion.

  本发明提供了一种具有优越的湿热性能等特性的复合物等，用于光记录介质，包括：下式中所表示的化合物（在该式中，R1代表一个可能具有一个或多个取代基的烷基基团等，R2代表一个氰基等，R3代表一个可能具有一个或多个取代基的烷基基团等，R4代表一个氢原子等，R5代表下式（III）（在该式中，环A代表一个可能具有一个或多个取代基的杂环，其中该杂环是从嘧啶环、四唑环等中任选的任一环）]；一种金属；以及从由一个或多个质子加到胺上形成的离子、铵离子和季铵离子组成的群体中选择的任一离子。
• NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS
  申请人：APOSENSE LTD.

  公开号：US20150064111A1

  公开（公告）日：2015-03-05

  The invention relates to compounds and use thereof in the diagnosis and/or in treatment of medical disorders. In some embodiments, the compounds may be used for detecting a cancer. The compound may include a di-acid moiety. In some embodiments the di-acid moiety comprises a di-carboxylic acid and in some embodiments the di-acid moiety comprises a di-tetrazole.

  本发明涉及化合物及其在诊断和/或治疗医学疾病中的用途。在某些实施例中，该化合物可以用于检测癌症。该化合物可以包括二酸基团。在某些实施例中，二酸基团包括二羧酸基团，在某些实施例中，二酸基团包括二四氮唑基团。
• DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET
  申请人：FUJI CHEMICAL INDUSTRY CO., LTD.

  公开号：EP2465539A1

  公开（公告）日：2012-06-20

  There has been a need for an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity and can sustain a sufficient hardness even under humid conditions after opening. Disclosed are a disintegrating particle composition which is prepared by dispersing, in the presence of water, mannitol, xylitol, an inorganic excipient, a disintegrating agent and carmellose and drying, and an orally rapidly disintegrating tablet which comprises said disintegrating particle composition, an active substance and a disintegrating agent. The disintegrating tablet has a good texture and taste, an appropriate hardness and good disintegrating properties and can sustain a sufficient hardness under humid conditions.

  人们需要一种口服快速崩解片剂，这种片剂在口腔中具有良好的质地和口感，有足够的硬度，不会担心在生产或运输过程中碎裂或沾上灰尘，在口腔中具有良好的崩解性能，即使在开封后潮湿的条件下也能保持足够的硬度。本发明公开了一种崩解颗粒组合物，其制备方法是在有水存在的情况下，将甘露醇、木糖醇、无机赋形剂、崩解剂和卡麦芽糖分散并干燥；还公开了一种口服快速崩解片剂，其包括所述崩解颗粒组合物、活性物质和崩解剂。该崩解片具有良好的质地和口感、适当的硬度和良好的崩解性能，并能在潮湿条件下保持足够的硬度。
• Antimicrobial medical devices
  申请人：Becton, Dickinson and Company

  公开号：US10806829B2

  公开（公告）日：2020-10-20

  Medical devices comprise a polymeric body comprising: a base polymeric formulation comprising at least a polymer or co-polymer of propylene; and an additive comprising a copolymer having a polypropylene backbone and hybrid micromolecule side-chains based on organo-functional silanes (PP-g-XSiOA) in the presence of a co-agent, for example, difunctional metallic diacrylate monomers, where “X” is an organic group or an organo-functional group, and “A” is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material. X may be derived from a compound selected from the group consisting of epoxy, amino, acrylate, methacryloxy, and vinyl; and A is selected from the group consisting of: silicon, (Si), aluminum (Al), iron (Fe), titanium (Ti), silver (Ag), zinc (Zn), nickel (Ni), calcium (Ca), copper (Cu), tin (Sn); oxides thereof; hydroxides thereof; and mixtures of the foregoing. Antimicrobial agents are included in the polymeric body. The medical devices have enhanced antimicrobial properties.

  医疗器械由聚合物主体组成，聚合物主体包括一种基础聚合物配方，至少包含一种丙烯聚合物或共聚物；以及一种添加剂，包含一种共聚物，该共聚物具有聚丙烯骨架和基于有机官能硅烷（PP-g-XSiOA）的杂化微分子侧链，并存在一种助剂，例如双官能金属二丙烯酸酯单体，其中 "X "为有机基团或有机官能基团，"A "为金属、无机氧化物、无机氢氧化物或任何其他无机材料。X 可以来自选自环氧基、氨基、丙烯酸酯、甲基丙烯酰氧基和乙烯基的化合物；A 选自以下组别：硅 (Si)、铝 (Al)、铁 (Fe)、钛 (Ti)、银 (Ag)、锌 (Zn)、镍 (Ni)、钙 (Ca)、铜 (Cu)、锡 (Sn)；其氧化物；其氢氧化物；以及上述物质的混合物。抗菌剂包含在聚合物体中。这种医疗器械具有更强的抗菌性能。